BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8504424)

  • 1. Relationship between circadian-dependent toxicity of 5-fluorodeoxyuridine and circadian rhythms of pyrimidine enzymes: possible relevance to fluoropyrimidine chemotherapy.
    Zhang R; Lu Z; Liu T; Soong SJ; Diasio RB
    Cancer Res; 1993 Jun; 53(12):2816-22. PubMed ID: 8504424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls.
    Raida M; Kliche KO; Schwabe W; Häusler P; Clement JH; Behnke D; Höffken K
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):96-102. PubMed ID: 11862480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian variation of 5-fluorouracil catabolism in isolated perfused rat liver.
    Harris BE; Song RL; Soong SJ; Diasio RB
    Cancer Res; 1989 Dec; 49(23):6610-4. PubMed ID: 2819711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian variation of fluoropyrimidine catabolic enzymes in rat liver: possible relevance to 5-fluorodeoxyuridine chemotherapy.
    Daher GC; Zhang RW; Soong SJ; Diasio RB
    Drug Metab Dispos; 1991; 19(1):285-7. PubMed ID: 1673417
    [No Abstract]   [Full Text] [Related]  

  • 5. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian rhythm of rat liver dihydropyrimidine dehydrogenase. Possible relevance to fluoropyrimidine chemotherapy.
    Harris BE; Song RL; He YJ; Soong SJ; Diasio RB
    Biochem Pharmacol; 1988 Dec; 37(24):4759-62. PubMed ID: 3202908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
    Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
    Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The time of administration of 3'-azido-3'-deoxythymidine (AZT) determines its host toxicity with possible relevance to AZT chemotherapy.
    Zhang R; Lu Z; Diasio CR; Liu T; Soong SJ
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1771-6. PubMed ID: 8239582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dihydropyrimidine deshydrogenase (DPD): rhythm and consequences].
    Barrat-Petit MA; Naulin-Ifi C; Mahler P; Milano G
    Pathol Biol (Paris); 2005 Jun; 53(5):261-4. PubMed ID: 15939134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Link between dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells and liver.
    Chazal M; Etienne MC; Renée N; Bourgeon A; Richelme H; Milano G
    Clin Cancer Res; 1996 Mar; 2(3):507-10. PubMed ID: 9816197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.
    Okuda H; Ogura K; Kato A; Takubo H; Watabe T
    J Pharmacol Exp Ther; 1998 Nov; 287(2):791-9. PubMed ID: 9808711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian variations in the activities of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in the liver of control and streptozotocin-induced diabetic rats.
    Ulusu NN; Ozbey G; Tandogan B; Gunes A; Durakoglugil DB; Karasu C; Uluoglu C; Zengil H
    Chronobiol Int; 2005; 22(4):667-77. PubMed ID: 16147898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of two fluorouracil administration regimens for colorectal cancer.
    Matsusaka S; Yamasaki H; Kitayama Y; Okada T; Maeda S
    Oncol Rep; 2003; 10(1):109-13. PubMed ID: 12469154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydropyrimidine dehydrogenase activity and fluorouracil pharmacokinetics with liver damage induced by bile duct ligation in rats.
    Tateishi T; Watanabe M; Nakura H; Tanaka M; Kumai T; Sakata SF; Tamaki N; Ogura K; Nishiyama T; Watabe T; Kobayashi S
    Drug Metab Dispos; 1999 Jun; 27(6):651-4. PubMed ID: 10348793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene.
    van Kuilenburg AB; Haasjes J; Richel DJ; Zoetekouw L; Van Lenthe H; De Abreu RA; Maring JG; Vreken P; van Gennip AH
    Clin Cancer Res; 2000 Dec; 6(12):4705-12. PubMed ID: 11156223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian rhythm of rat spleen cytoplasmic thymidine kinase.
    Zhang R; Lu Z; Liu T; Soong SJ; Diasio RB
    Biochem Pharmacol; 1993 Mar; 45(5):1115-9. PubMed ID: 8461041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian rhythmicity in DNA synthesis in untreated and saline-treated mice as a basis for improved chronochemotherapy.
    Burns ER
    Cancer Res; 1981 Jul; 41(7):2795-802. PubMed ID: 7248943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer.
    Tsuji T; Sawai T; Takeshita H; Nakagoe T; Hidaka S; Yamaguchi H; Yasutake T; Nagayasu T; Tagawa Y
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):531-6. PubMed ID: 15309506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circadian rhythms of DNA synthesis and apoptosis correlated gene expression in bone marrow cells of nude mice bearing human nasopharyngeal carcinoma].
    Sun J; Xian LJ; Cao QY; Ye YL; Zeng ZL; Liu XH; Li XM; Levi F
    Ai Zheng; 2002 Aug; 21(8):833-7. PubMed ID: 12478887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian rhythm of dihydrouracil/uracil ratios in biological fluids: a potential biomarker for dihydropyrimidine dehydrogenase levels.
    Jiang H; Lu J; Ji J
    Br J Pharmacol; 2004 Feb; 141(4):616-23. PubMed ID: 14744810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.